Atlas Trials

Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

Clinical trial NCT05381311 · COMPLETED

Trial details

NCT number
NCT05381311
Sponsor
Astellas Pharma Global Development, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate CancerMetastatic Hormone-sensitive Prostate Cancer
Start date
2021-09-03
Primary completion
2022-12-11
Enrollment
1020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.